ScaffidiJMolBWKeelanJA. The pregnant women as a drug orphan: A global survey of registered clinical trials of pharmacological interventions in pregnancy. BJOG2017; 124: 132–140.
2.
FernandezODelvecchioMEdanGet al. Survey of diagnostic and treatment practices for multiple sclerosis (MS) in Europe. Part 2: Progressive MS, paediatric MS, pregnancy and general management. Eur J Neurol2018; 25: 739–746.
3.
SpongCYBianchiDW. Improving public health requires inclusion of underrepresented populations in research. JAMA2018; 319: 337–338.
4.
AlvarezEMowryE. We need to conduct clinical trials of disease-modifying therapy in pregnancy to optimize care of women with MS – Yes. Mult Scler2019; 25: 187–188.
5.
HellwigK. We need to conduct clinical trials of disease-modifying therapy in pregnancy to optimize care of women with MS – No. Mult Scler2019; 25: 189–190.
6.
ConnickPDe AngelisFParkerRAet al. Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): A multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis. BMJ Open2018; 8: e021944.
7.
RubinR. Addressing barriers to inclusion of pregnant women in clinical trials. JAMA2018; 320: 742–744.
8.
ChitnisTArnoldDLBanwellBet al. Trial of fingolimod versus interferon beta-1a in pediatric multiple sclerosis. N Engl J Med2018; 379: 1017–1027.
9.
StrommerSLawrenceWRoseTet al. Improving recruitment to clinical trials during pregnancy: A mixed methods investigation. Soc Sci Med2018; 200: 73–82.
10.
Oude RengerinkKLogtenbergSHooftLet al. Pregnant women’s concerns when invited to a randomized trial: A qualitative case control study. BMC Pregnancy Childb2015; 15: 207.
11.
LyerlyADNameyEEGrayBet al. Women’s views about participating in research while pregnant. IRB2012; 34: 1–8.
